THC Farmaceuticals, Inc.

CBDG

US87243T1007

Drug Retailers

Delayed OTC Markets Other stock markets 09:35:28 2024-04-22 am EDT			5-day change	1st Jan Change
0.043 ^USD	+167.08%		+167.08%	+95.45%

2023	THC Farmaceuticals, Inc. announced that it expects to receive $0.124 million in funding	CI
2021	Thc Farmaceuticals, Inc. Announces Final Departure of Mike Gravel, Chairman	CI

THC Farmaceuticals, Inc. Appoints Mike Gravel as Chief Executive Officer and Chairman of the Board

May 20, 2015 at 05:30 pm EDT

On May 15, 2015, Former U.S. Senator Mike Gravel was appointed as Chief Executive Officer of THC Farmaceuticals, Inc. and elected to serve on board of directors as chairman of the Board. Senator Gravel is the former United States Senator from the State of Alaska having served two terms from 1969 to 1981 and was a Democratic and Libertarian Party candidate for President of the United States in 2008.

Latest news about THC Farmaceuticals, Inc.

THC Farmaceuticals, Inc. announced that it expects to receive $0.124 million in funding	23-02-07	CI
Thc Farmaceuticals, Inc. Announces Final Departure of Mike Gravel, Chairman	21-06-28	CI
THC Farmaceuticals, Inc. Announces Departure of Its CEO, Mike Gravel	21-06-28	CI
THC Farmaceuticals, Inc. acquired 51% stake in GK Manufacturing and Packaging, Inc. from Cannabis Sativa, Inc. for $0.9 million.	21-05-03	CI
THC Farmaceuticals, Inc. and Rubin's Dental Anxiety Pills entered into a binding agreement to acquire an unknown majority stake in GK Manufacturing and Packaging, Inc. from Cannabis Sativa, Inc..	21-05-03	CI
CBDual Biotechnology Corp., Subsidiary of THC Farmaceuticals, Inc. Completes the Research and Development of New CBD Based Dental Anxiety Formulation	20-12-07	CI
Jon McGee Resigns as an Officer and Director of THC Farmaceuticals	15-09-03	CI
THC Farmaceuticals, Inc. Appoints Ed Rosenthal as President	15-06-29	CI
THC Farmaceuticals, Inc. Appoints Mike Gravel as Chief Executive Officer and Chairman of the Board	15-05-20	CI
THC Farmaceuticals, Inc. Announces Resignation of Patrick Bilton as Director	15-04-13	CI
City Media, Inc. will Change its Name to THC Farmaceuticals, Inc	15-04-08	CI
City Media, Inc. will Change its Ticker to CBDG from CTYM	15-01-20	CI
City Media, Inc. Announces Board Changes	14-12-23	CI
Weed Growth Fund, Inc. acquired 62.72% stake in City Media, Inc. (OTCQB: CTYM) from Thomas Howells, Travis Jenson, Kelly Trimble, Calvin Jones and Jennifer Aguirre for $0.25 million.	14-11-20	CI

Chart THC Farmaceuticals, Inc.

Duration

Period

More charts

Company Profile

THC Farmaceuticals, Inc. is a clinical-stage biotechnology company. The Company specializes in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology and other medical disciplines. It offers the combination of its proprietary developments with its clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds. The Company owns clinical research center and cannabidiol (CBD) manufacturing facility in California. Its business plan includes conducting cannabinoids research and development in collaboration with cannabis research centers worldwide with the goal of developing novel and advanced therapeutic methods for the treatment of common medical conditions with cannabis-based therapies and to conduct pre-clinical investigations and randomized, placebo-controlled trials of CBD-based compounds and develop condition-specific medications. It offers a network of micro vending kiosk systems.

Sector

Drug Retailers

More about the company

Sector Cannabis Product Retailers

	1st Jan change	Capi.
THC FARMACEUTICALS, INC.	+95.45%	780K
GREEN THUMB INDUSTRIES INC.	+9.35%	2.91B
VERANO HOLDINGS CORP.	+14.12%	1.69B
GLASS HOUSE BRANDS INC.	+79.60%	625M
TERRASCEND CORP.	+2.27%	485M
HIGH TIDE INC.	+24.41%	159M
CANTOURAGE GROUP SE	+9.33%	108M
NOVA CANNABIS INC.	+52.81%	56.96M

Cannabis Product Retailers